PMD Stock - Psychemedics Corporation
Unlock GoAI Insights for PMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $19.68M | $22.10M | $25.24M | $24.91M | $21.36M |
| Gross Profit | $7.10M | $8.41M | $9.29M | $10.26M | $4.89M |
| Gross Margin | 36.1% | 38.1% | 36.8% | 41.2% | 22.9% |
| Operating Income | $-1,893,000 | $-2,921,000 | $-1,083,000 | $-3,481,000 | $-6,066,000 |
| Net Income | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 | $-3,859,000 |
| Net Margin | -9.5% | -18.8% | -4.3% | -2.7% | -18.1% |
| EPS | $-0.32 | $-0.72 | $-0.19 | $-0.12 | $-0.70 |
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Visit WebsiteEarnings History & Surprises
PMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 10, 2025 | — | — | — | — |
Q3 2025 | Aug 11, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q1 2025 | Mar 24, 2025 | — | $0.03 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.09 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.14 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.12 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.16 | — | — |
Q4 2023 | Nov 9, 2023 | — | $-0.36 | — | — |
Q3 2023 | Aug 11, 2023 | — | $-0.13 | — | — |
Q2 2023 | May 9, 2023 | — | $-0.07 | — | — |
Q1 2023 | Mar 21, 2023 | — | $-0.12 | — | — |
Q4 2022 | Nov 9, 2022 | — | $-0.02 | — | — |
Q3 2022 | Aug 9, 2022 | — | $-0.06 | — | — |
Q2 2022 | May 10, 2022 | — | $0.01 | — | — |
Q1 2022 | Mar 29, 2022 | — | $-0.29 | — | — |
Q4 2021 | Nov 12, 2021 | — | $0.13 | — | — |
Q3 2021 | Aug 10, 2021 | — | $0.02 | — | — |
Q2 2021 | May 10, 2021 | — | $0.01 | — | — |
Q1 2021 | Mar 23, 2021 | — | $-0.10 | — | — |
Latest News
Frequently Asked Questions about PMD
What is PMD's current stock price?
What is the analyst price target for PMD?
What sector is Psychemedics Corporation in?
What is PMD's market cap?
Does PMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PMD for comparison